NCT06478069

Brief Summary

This study focuses on a two-pronged strategy to enhance the rehabilitation of stroke patients. It first investigates the application of pose estimating technologies to objectively measure posture.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 10, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 27, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

June 27, 2024

Status Verified

June 1, 2024

Enrollment Period

7 months

First QC Date

June 10, 2024

Last Update Submit

June 26, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Berg Balance Scale

    For evaluating balance in a variety of functional tasks, the BBS is a commonly used and validated test. After the intervention period, the BBS scores of the control group and the intervention group (who received DCS techniques) can be compared. The efficacy of DCS in enhancing postural control would be strongly supported by a statistically significant increase in the intervention group's BBS score.

    12 Months

  • Trunk Impairment Scale (TIS) Score

    The total score for TIS ranges between 0 for a minimal performance to 23 for a perfect performance. In a recent version of the TIS (version 2.0) for adults, the static subscale was removed because of a ceiling effect, total score ranges between 0 and 16 points

    12 months

Study Arms (2)

Group A

OTHER
Diagnostic Test: Group A

Group B

EXPERIMENTAL
Behavioral: Group B

Interventions

Group ADIAGNOSTIC_TEST

Group A was treated with Ibuprofen Dosage After breakfast and after dinner for 6 weeks.

Group A
Group BBEHAVIORAL

Group B was treated with physical therapy; (Upper limb: The stroke patient warmed up with some gentle stretches for the wrist and fingers to get the muscles ready. They subsequently engaged in resistance training using dumbbells or resistance bands to increase the strength of their upper limbs. Bicep curls, tricep extensions, and shoulder presses were some of these exercises. They tried to complete two to three sets of ten to fifteen repetitions for each exercise, progressively increasing the resistance as their strength increased. Then, to improve dexterity and coordination in daily tasks, functional exercises were included.

Group B

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke, either ischemic or hemorrhagic
  • Standing ability and ability to perform basic movements with assistance
  • Willingness to take part in the intervention and evaluations

You may not qualify if:

  • Severe cognitive impairment hindering participation
  • Unstable medical conditions affecting rehabilitation
  • History of other neurological disorders affecting posture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sevices Hospital Shadman 1

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Stroke

Interventions

Chromosomes, Human, 1-3

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Chromosomes, HumanChromosomes, MammalianChromosomesGenetic StructuresGenetic Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 10, 2024

First Posted

June 27, 2024

Study Start

October 1, 2023

Primary Completion

May 1, 2024

Study Completion

September 30, 2024

Last Updated

June 27, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations